ArticlePediatric nephrology (Berlin, Germany)2013

Eculizumab therapy for atypical haemolytic uraemic syndrome due to a gain-of-function mutation of complement factor B.

Rodney D Gilbert et al.PubMed ↗Publisher ↗

No numbers read from the abstract.